Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

July 2007

Nobel CEO Heliane Canepa Steps Down BY DAVID KRESSEL, JULY 31, 2007

Nobel Biocare announced that CEO Heliane Canepa would leave the company, effective September 1. Her replacement will be Domenico Scala, CFO of Syngenta and a Director of Nobel. According to the company, this change is the result of a year-long... more

Orthofix Receives Subpoena from OIG BY DAVID KRESSEL, JULY 30, 2007

Orthofix announced via an 8-K filing that its Blackstone Medical subsidiary received a subpoena from the Department of Health and Human Service's Office of the Inspector General (OIG). The 8-K stated the investigation concerns physician consultant compensation as it relates... more

Medtronic to Acquire Kyphon BY ARIELLA P. GOLOMB, MD, JULY 27, 2007

Further solidifying its market-leading position in the spine industry, Medtronic today announced plans to acquire Kyphon for approximately $3.9 billion, excluding $320 million in payments for Kyphon's St. Francis Medical and Disc-O-Tech acquisitions. Additionally, there is a break up fee... more

Synthes vs. Globus: Round 1 and the Gloves are Off BY JOHN MCCORMICK, JULY 27, 2007

What is going on with the now famous David and Goliath Synthes vs. Globus legal battle? Is it a nuisance suit designed by Synthes to distract Globus management or does it have merit? Over the last three years the docket... more

Musculoskeletal News Roundup 26-July-07 BY LAUREN UZDIENSKI, JULY 26, 2007

Earnings Stryker reported revenues of $1.46 billion, beating estimates of $1.44 billion and increasing 16% from $1.26 billion in 2Q:06. 2Q:07 earnings were $269.1 million, or $0.65 per share, beating estimates of $0.61 and up from $0.52 in the comparable... more

FDA to Change Inspection Policy BY ED ROSS, JULY 25, 2007

In the coming months, the FDA plans to implement significant changes in how the agency conducts inspections. First, the FDA plans to close seven regional offices within the Office of Regulatory Affairs (ORA), leaving only six operational. Remaining offices will... more

TranS1 Files for $80 Million IPO BY JOHN MCCORMICK, JULY 25, 2007

Spine company TranS1 registered for an initial public offering of common stock yestderday. Like all IPOs, TranS1 has a few hurdles to pass through before actually going public, but the company has taken the first important step which is to... more

An Ortho Stock Index Now Trading BY JOHN MCCORMICK, JULY 23, 2007

Every so often we get the question at the trade shows - how do I buy all of the ortho stocks at once? In the past, our only answer was you had to buy representative shares of every ortho stock... more

Alphatec Holdings, Inc. Appoints Mortimer Berkowitz III Chairman of the Board of Directors BY EDITOR, JULY 23, 2007

Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that Mortimer Berkowitz III was appointed to serve as Alphatec's Chairman of... more

Scient'x reaches milestone of 1.000 second-generation cervical disc prosthesis implanted worldwide BY EDITOR, JULY 20, 2007

Paris, July 19, 2007 - Scient'x, a privately-held company dedicated to spinal implants, announced today that its second-generation cervical disc prosthesis has been implanted in 1.000 patients worldwide. The Discocerv artificial disc offers a unique design to restore normal biomechanical... more

Musculoskeletal News Roundup 19-July-07 BY LAUREN UZDIENSKI, JULY 19, 2007

M&A DJO announced on Monday plans for merger with ReAble (formerly Encore Medical). ReAble will acquire all outstanding shares of DJO stock, a transaction valued at approximately $1.6 billion and including the assumption of debt. The transaction will be funded... more

Encouraging Data for GEM OS1 BY LAUREN UZDIENSKI, JULY 19, 2007

At the AOFAS meeting last week, BioMimetic Therapeutics reported further positive interim data from its ongoing clinical trials of GEM OS1 in foot and ankle fusion indications. The U.S. arm of the study is a randomized, prospective, controlled pilot study... more

FDA Panel Supports BRYAN Cervical Disc, but not Superiority Claim BY JOHN MCCORMICK, JULY 17, 2007

Today was a long day in Gaithersburg, Maryland exploring the ins and outs of wear debris and Bayesian statistics. Luckily the dirty work was left to an 11-member panel of sober experts appointed by the FDA to make recommendations on... more

AOSSM Goes Cowboy in Calgary BY ELIZABETH VARLEY CAMP, JULY 17, 2007

Calgary was the host city for this year's AOSSM conference last week, which coincided with the Stampede, the world's largest rodeo event. No Calgary citizen seemed to be working this week; all were enjoying perfect weather, pancake breakfasts and BBQ... more

Medtronic's Prestige Cervical Disc Receives FDA Approval BY ARIELLA P. GOLOMB, MD, JULY 17, 2007

Medtronic announced yesterday that the company received conditional FDA approval for its Prestige® Cervical Disc, the first cervical disc to be marketed in the U.S. Approval is contingent upon a seven-year post-approval study to evaluate long-term safety and effectiveness. The... more

DJO to sell for $1.6 Billion BY JOHN MCCORMICK, JULY 16, 2007

This morning DJO Incorporated (formerly known as DJ Orthopedics), the largest bracing company in the land, announced that it has agreed to be sold for $1.6 billion to Austin, Texas-based ReAble Theraputics, Inc. (formerly known as Encore Medical). As opposed... more

CMS Revises their Clinical Trial Policy; More Changes to Come BY LAUREN UZDIENSKI, JULY 13, 2007

On Monday, CMS released a brief Decision Memo on changes to the agency's Clinical Trials Policy. The proposed decision was first announced in April and followed by a public comment period. The memo notes two important changes. One, the final... more

Musculoskeletal News Roundup 12-July-07 BY LAUREN UZDIENSKI, JULY 12, 2007

M&A Biomet Inc. shareholders accepted an $11.4 billion buyout offer from a private equity consortium attempting to acquire the medical device maker. The consortium, LVB Acquisition LLC, announced Thursday that nearly 83 percent of Biomet's shares were tendered. The company... more

About Our New Look BY EDITOR, JULY 10, 2007

As you’ve probably noticed, the HealthpointCapital website is featuring a fresh new design. There are also several functional and content upgrades. Read on to learn about them. more

Los Cabos: An Expansive Spine Meeting BY JOHN MCCORMICK, JULY 9, 2007

The week prior to the 4th, we attended the Spine Technology Education Group meeting in Los Cabos, Mexico, which addressed numerous topics on innovative techniques in spine surgery. Kudos to Drs. Phillips, Albert and Vaccaro for organizing a meeting that... more

Orthopedic News Roundup 5-July-07 BY LAUREN UZDIENSKI, JULY 5, 2007

Regulatory Corin received FDA approval for its Cormet Hip Resurfacing System on Tuesday, following an approval recommendation from an FDA Advisory panel back in February. Conditions of the official approval include the creation of a surgeon education protocol that emphasizes... more

Cormet Gets FDA Approval, Stryker To Market As Early As 3Q:07 BY ARIELLA P. GOLOMB, MD, JULY 5, 2007

On Tuesday the FDA approved Corin's Cormet Hip Resurfacing System, introducing competition for Smith & Nephew's Birmingham Hip Resurfacing System in the U.S. Prior to Tuesday's announcement, the BHR was the only resurfacing system approved for the U.S. market. An... more

Upcoming Patent Reform Changes BY ED ROSS, JULY 3, 2007

The Patent Reform Act of 2007 has faced heavy opposition since its introduction in the House in April, notably from the MDMA and other industry groups. These organizations believe the proposed revisions to U.S. patent law would "undermine the value... more


Complete Archive